Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
Categories: News

Satya Therapeutics Hits Major Psilocybin Milestones, Leading in Healing, Accessibility, and Industry Leadership

ASHLAND, OR AND MEDFORD, OR / ACCESS Newswire / January 8, 2026 / Satya Therapeutics™, Oregon’s top licensed psilocybin service center and manufacturer, celebrates a string of milestones that underscore its role as a leader in accessible, life-changing psilocybin therapy.

  • 1,400th Client Served: In January 2026, Satya’s Ashland Service Center will welcome its 1,400th client, making it the highest-volume psilocybin therapy centers in the USA.

  • 130+ Google Reviews: Clients consistently praise Satya’s compassionate facilitation, safe environment, and transformative sessions, highlighting why the center leads the industry in positive feedback.

  • 50,000th mg of Psilocybin Administered: January also marks the delivery of 50,000 milligrams of psilocybin to clients, reflecting both quality and deep personalized care.

  • Affordable, All-Inclusive Journeys: Satya offers all-inclusive psilocybin sessions for $850, led by a licensed facilitator including preparation and integration sessions, the service center cost and the cost of psilocybin-making healing more accessible than any other service center in the U.S.

  • Clients Travel from Other States: Even with 30+ licensed centers in Colorado, clients choose Satya for experience, positive reviews, and high-quality, cost-effective therapy.

  • Regulatory Leadership: Many service centers face closure due to regulatory hurdles and high costs, but Satya continuously adapts, advocating for safe, sustainable, and accessible psilocybin therapy.

  • 75,000th mg Psilocybin Manufactured: Satya maintains the lowest wholesale pricing in Oregon (under $1/mg), supplying seven other service centers and holding an estimated 33% market share statewide.

  • Innovative Strain Hunt: Satya is expanding its Melange series of blended psilocybin products, targeting high-psilocin strains for clients on SSRIs or antipsychotic medications, broadening therapeutic options and outcomes.

About Satya Therapeutics
Satya Therapeutics is a licensed psilocybin service center and producer based in Ashland and Medford, Oregon. Its mission is to provide safe, transformative, and affordable psilocybin-assisted experiences through expert facilitation, compassionate care, and high-quality standards.

Learn more at satyatherapeutics.com.

Media Contact:
Satya Therapeutics
Tel: (541) 930-2478
Email: andreas@satyatherapeutics.com
Website: satyatherapeutics.com

SOURCE: SATYA INC.

View the original press release on ACCESS Newswire

Staff

Recent Posts

Tetra Tech Awarded $14 Million DLA Technology Task Order Contract

PASADENA, Calif.--(BUSINESS WIRE)--#cybersecurity--Tetra Tech, Inc. (NASDAQ: TTEK), a leading provider of high-end consulting and engineering…

8 hours ago

SetSale Closes $2 Million to Bring AI Efficiency to the HVAC Supply Chain

Funding to Help Contractors Optimize Their Sales Processes with AI and Break Down Silos Between…

14 hours ago

Topsort Launches Tomi, ​​an AI Agent to Automate Retail Media Campaign Operations

New AI-native capability enables marketplaces to launch and manage sponsored listing campaigns in seconds through…

14 hours ago

Elektros Initiates Strategic Licensing Discussions With Major Electric Vehicle Manufacturers

Breakthrough Multi‑Port EV Charging Patent Could Transform Electric Vehicle Charging Times SUNNY ISLES BEACH, FL…

14 hours ago

Tianci International, Inc. Announces Reverse Stock Split

Shares Expected to Begin Trading on Split-Adjusted Basis on March 20, 2026 HONG KONG, HK…

14 hours ago

MANTA Subsea Cable Consortium Selects MDC Data Centers as Neutral Landing Partner in Mexico

Liberty Networks, Gold Data, and Sparkle will land the MANTA subsea cable system in Cancún…

14 hours ago